Source: Breathe 2015; 11:233-236
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Galiè Nazzareno, Manes Alessandra, Palazzini Massimiliano. GPs Meet Rare Lung Disorders Task Force factsheet: pulmonary arterial hypertension. Breathe 2015; 11:233-236

Member's Comments

No comment yet.

Related content which might interest you: GPs Meet Rare Lung Disorders Task Force factsheet: childhood interstitial lung disease Source: Breathe 2014; 10:173-175 Year: 2014 GPs Meet Rare Lung Disorders Task Force factsheet: cystic fibrosis Source: Breathe 2014; 10:345-347 Year: 2014 GPs Meet Rare Lung Disorders Task Force factsheet: lung disease in children with immunodeficiencies Source: Breathe 2014; 10: 271-272 Year: 2014 GPs Meet Rare Lung Disorders Task Force factsheet: primary ciliary dyskinesia Source: Breathe 2015; 11:159-161 Year: 2015 GPs Meet Rare Lung Disorders Task Force factsheet: alpha-1 antitrypsin deficiency Source: Breathe 2014; 10: 87-89 Year: 2014 Members of the Task Force on Recognizing and Diagnosing Exercise-Related Asthma, Respiratory and Allergic Disorders in Sports Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-22-7, page=105 Year: 2005 Ceremony for the ERS Pulmonary Arterial Hypertension Lifetime Achievement Research Award Source: International Congress 2017 – Open questions in pulmonary vascular diseases Year: 2017 Choir in the Pulmonary Rehabilitation Program Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD Year: 2017 Is Virtual Autonomous Physiotherapist Tele-rehabilitation Program in Chronic Obstructive Pulmonary Disease equal to Hospital-Based Pulmonary Rehabilitation? Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine Year: 2020 Ceremony for ERS Award for Lifetime Achievement in Pulmonary Arterial Hypertension Source: International Congress 2016 – Pulmonary arterial hypertension: future therapeutic approaches Year: 2016 Ceremony for the ERS Award for Lifetime Achievement in Pulmonary Arterial Hypertension Source: Annual Congress 2013 –Ceremony for the ERS Award for Lifetime Achievement in Pulmonary Arterial Hypertension (financially supported by Actelion) followed by Symposium: Drug-induced pulmonary arterial hypertension Year: 2013 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Source: Eur Respir J 2015; 46: 903-975 Year: 2015 Severe Pulmonary Hypertension Management Across Europe (PHAROS): an ERS Clinical Research Collaboration Source: Eur Respir J, 55 (5) 2001047; 10.1183/13993003.01047-2020 Year: 2020 Evaluation of COPD Patient’s Relatives Assessment of Disease Awarness, Load of Care Giving and Loss of Workforce: Turkish Thoracic Society COPD Working Group. Source: International Congress 2018 – Patient-reported outcomes and scores in COPD Year: 2018 European Respiratory Society Guideline on Long-term Home Non-Invasive Ventilation for Management of Chronic Obstructive Pulmonary Disease Source: Guideline 2019 Year: 2019 Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline Source: Guideline 2018 Year: 2018 Impact of Pulmonary Hypertension on the Response to Pulmonary Rehabilitation in Obstructive Lung Disease Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today Year: 2019